Immunovant (IMVT) CFO Tiago Girao Sells 6,798 Shares

What Happened
Tiago Girao, Chief Financial Officer of Immunovant (IMVT), sold 6,798 shares on July 23, 2026, generating approximately $263,015. The sale was a mandated "sell-to-cover" transaction to satisfy tax withholding obligations related to the vesting and settlement of previously granted restricted stock units (RSUs), not a discretionary open-market trade.

Key Details

• Transaction date: 2026-07-23; Form 4 filed 2026-07-24 (timely filing).
• Transaction type: Sale (S) — sell-to-cover to satisfy tax withholding.
• Shares sold: 6,798 at a weighted average price of $38.69 per share; prices in the batch ranged $38.18–$39.05. Total proceeds ≈ $263,015.
• Triggering grant/vesting: 208,388 RSUs were originally granted on May 1, 2025; 13,024 RSUs vested on July 21, 2026. The reported sale covered tax withholding from that vesting (Footnote F1).
• Footnote F2: weighted average price reported; issuer can provide breakdown by price on request.
• Shares owned after the transaction: not specified in the provided filing.

Context
This was a routine, company-mandated sell-to-cover tied to RSU tax obligations — common when equity awards vest. Such transactions are generally administrative (tax-related) rather than indicators of the insider’s view on the company’s prospects.